Which MS drug fights fatigue better? new study aims to find out
NCT ID NCT06843382
First seen Nov 21, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study looks at two common multiple sclerosis (MS) medications, teriflunomide and dimethyl fumarate, to see how they affect physical and mental fatigue during everyday activities. Researchers will follow 100 adults with MS for one year, measuring walking endurance, hand function, and thinking speed at regular visits. The goal is to help patients and doctors choose the best treatment for managing fatigue in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erciyes University
Kayseri, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.